We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: Cardiology

Impacts of Plant-Based Diets on Multimorbidity Risk in Cancer and Cardiometabolic Diseases Across Age Groups

MedXY Editorial Team•Oct 20, 2025•Cardiology
cancercardiometabolic diseasesepidemiologymultimorbidityplant-based diet

Highlight

This prospective analysis combining data from the EPIC and UK Biobank cohorts involving over 400,000 European adults aged 35 to 70 found that higher adherence to a healthful plant-based diet is associated with a significantly reduced risk of developing multimorbidity, defined as coexisting cancer and cardiometabolic diseases. The protective effect was particularly pronounced in middle-aged adults under 60 years. Conversely, an unhealthful plant-based diet correlated with increased multimorbidity risk in the UK Biobank but was not confirmed in EPIC.

Background

Multimorbidity, the coexistence of two or more chronic non-communicable diseases such as cancer, cardiovascular disease (CVD), and type 2 diabetes (T2D), represents a growing global health challenge. It complicates clinical management, reduces quality of life, and increases mortality risk. While plant-based diets have been shown to reduce the incidence of individual chronic diseases, it remains unclear whether they influence progression from an initial diagnosis to multimorbidity across the cancer and cardiometabolic spectrum. Additionally, understanding how these diet–disease relationships vary with age may refine prevention strategies for different life stages.

Study Design

This study was a large prospective cohort analysis including 407,618 participants (226,324 from the European Prospective Investigation into Cancer and Nutrition [EPIC] and 181,294 from the UK Biobank), aged 35 to 70 years at baseline recruitment across six European countries. Participants with pre-existing cancer, CVD, or T2D were excluded to focus on incident multimorbidity risk. Dietary data were collected at baseline using validated food frequency questionnaires in EPIC and through multiple 24-hour dietary recalls over approximately one year in the UK Biobank. Two dietary indices were constructed: a healthful Plant-Based Diet Index (hPDI) reflecting high consumption of nutritious plant foods, and an unhealthful Plant-Based Diet Index (uPDI) emphasizing less healthy plant foods like refined grains and sugary items.

The primary outcome was multimorbidity, defined as the development of at least two chronic diseases among cancer at any site, CVD, and T2D. The study employed multistate modeling with Cox proportional hazards regression to estimate hazard ratios (HRs) for multimorbidity per 10-point increment in diet index scores. Analyses were stratified by age groups younger than 60 years and 60 years or older to examine age-specific effects.

Key Findings

Over a median follow-up of approximately 11 years, 6,604 incident multimorbidity events were recorded. A higher hPDI was associated with a reduced risk of cancer-cardiometabolic multimorbidity in both cohorts. Specifically, in EPIC, a 10-point increase in hPDI was associated with an HR of 0.89 (95% confidence interval [CI], 0.83–0.96), and in UK Biobank, the HR was 0.81 (95% CI, 0.76–0.86), indicating approximately 11–19% lower risk. Notably, the inverse association was stronger among adults younger than 60 years. In UK Biobank, the protective effect was pronounced, with HRs of 0.71 (95% CI, 0.65–0.79) in younger participants and 0.86 (95% CI, 0.80–0.92) in older adults (p for interaction = 0.0016). In EPIC, similar trends were observed but with weaker effect size and nonsignificant interaction by age.

Regarding the unhealthful plant-based diet, UK Biobank participants showed a positive association with multimorbidity risk (HR per 10-point uPDI increment of 1.22; 95% CI, 1.16–1.29). However, this association was not replicated in the EPIC cohort (HR 1.00; 95% CI, 0.94–1.08), suggesting possible cohort differences or measurement variations.

Expert Commentary

This study provides robust epidemiological evidence supporting the protective role of healthy plant-based dietary patterns in reducing the multimorbidity burden involving cancer and cardiometabolic diseases. The use of large, well-characterized cohorts, exclusion of baseline disease cases, and advanced multistate modeling to account for disease progression strengthen causal inference.

The age-specific findings emphasize the potentially greater benefit of dietary interventions earlier in life before disease onset and progression. This is concordant with biological plausibility: plant-based diets rich in antioxidants, fiber, and phytochemicals can reduce systemic inflammation, improve metabolic and cardiovascular parameters, and modulate carcinogenesis.

The lack of replication in EPIC for the unhealthful plant-based diet index association highlights limitations including dietary assessment differences, regional dietary patterns, and residual confounding. Additionally, the observational design precludes definitive causality, and unmeasured lifestyle factors may influence outcomes. Future randomized controlled trials and mechanistic studies would be valuable for confirming and elucidating these relationships.

Conclusion

This large prospective analysis corroborates that adherence to a healthful plant-based dietary pattern is associated with a reduced risk of developing multimorbidity of cancer and cardiometabolic diseases, particularly when adopted before age 60. These findings reinforce current dietary guidelines advocating plant-forward nutrition to prevent chronic diseases and accentuate the importance of early lifestyle interventions for multimorbidity prevention. Nevertheless, further research is needed to clarify the differential effects of plant-based diet quality and to expand findings to diverse populations.

Funding and ClinicalTrials.gov

The study received funding from the Korean Government (Ministry of Science and ICT). No clinical trial registration was applicable as this analysis was based on cohort data.

References

1. Córdova R, Kim J, Thompson AS, et al. Plant-based dietary patterns and age-specific risk of multimorbidity of cancer and cardiometabolic diseases: a prospective analysis. Lancet Healthy Longev. 2025;6(8):100742. doi:10.1016/j.lanhl.2025.100742.
2. Satija A, Bhupathiraju SN, Spiegelman D, et al. Healthful and unhealthful plant-based diets and the risk of coronary heart disease in U.S. adults. J Am Coll Cardiol. 2017;70(4):411-422. doi:10.1016/j.jacc.2017.05.047
3. Willett WC, Ludwig DS. The science and practice of plant-based diets: Oncology and cardiovascular perspectives. JAMA. 2020;324(6):543-544. doi:10.1001/jama.2020.11417

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Optimizing Palliative Care for Effective Hospice Transitions in Cancer Patients: Insights from Multicenter Qualitative and Quantitative EvidenceThis review synthesizes evidence identifying critical programmatic factors, relational dynamics, and interventions enhancing hospice transitions in cancer palliative care, emphasizing collaborative oncology-palliative care relationships andSep 15, 2026Global Burden of Disorders of Gut-Brain Interaction: Insights from Rome V Versus Rome IV CriteriaThe Rome V global epidemiology survey confirms a high prevalence of disorders of gut-brain interaction (DGBI) worldwide, consistent with prior Rome IV findings, underscoring a significant and persistent global clinical burden.Sep 15, 2026Heart Failure in Portuguese Adults Aged 50 and Above: Insights from the PORTHOS Study on Prevalence and Predominant PhenotypesThe PORTHOS study reveals a 16.5% prevalence of heart failure among Portuguese adults aged 50+, with HFpEF constituting over 90% of cases, mostly undiagnosed, highlighting the need for enhanced screening strategies in aging populations.Sep 15, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Evolving Epidemiology and Survival Trends in Myeloproliferative Neoplasms: Insights from SEER 2000-2021
Analysis of SEER data from 2000-2021 reveals incidence, survival trends, and demographic disparities in US patients with myeloproliferative neoplasms, highlighting improved outcomes particularly in primary myelofibrosis and areas for furthe
Sep 13, 2026
High Pesticide Exposure Events and Olfactory Dysfunction: Integrating Subjective and Objective Evidence from Agricultural CohortsEmerging evidence links high pesticide exposure events (HPEEs) in farmers to increased self-reported olfactory dysfunction, though objective smell testing yields inconclusive associations, highlighting critical gaps and methodological consiSep 13, 2026
Incidence, Survival, and Symptomatology of Recurrence in Vulvar Cancer: Insights from Population-Based Cohort Studies and Contemporary EvidenceVulvar cancer exhibits significant recurrence rates, predominantly local, with survival declining sharply after recurrence. Awareness of recurrence-associated symptoms enhances early detection. Surgery remains pivotal in management, with frSep 12, 2026